deferiprone

	deferiprone
Trade Name	Ferriprox
Orphan Indication	Iron overload in patients with hematologic disorders requiring chronic transfusion therapy
USA Market Approval	USA
USA Designation Date	2001-12-12 00:00:00
Sponsor	ApoPharma, Inc. A Division of;Apotex Research Inc., Toronto, Canada M9L 1T9;